Home / Products / Cancer (Tumor) Cell Lines / SW780
SW780
Datasheet Protocol

SW780

Cat. No. ARC0926
Product Type:

Cancer (Tumor) Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Urinary bladder

Growth Properties:

Adherent

In stock
$1,300.00 / Vial
Ask a Question

Short Description 🔒

SW780 is a cancer cell line of urinary bladder transitional cell carcinoma, isolated from in situ; urinary bladder.

Recommended Products

Immortalized Human Cerebral Microvascular Endothelial Cell Immortalized Human Cerebral Microvascular Endothelial Cell Cat. No. ARI0294 Human Sebocytes Human Sebocytes Cat. No. ARP1187 PCBP3 Knockout jurkat Polyclonal Cells PCBP3 Knockout jurkat Polyclonal Cells Cat. No. ARG12894 NUDT7 Knockout A549 Polyclonal Cells NUDT7 Knockout A549 Polyclonal Cells Cat. No. ARG10504 MAN1A2 Knockout MES-OV Polyclonal Cells MAN1A2 Knockout MES-OV Polyclonal Cells Cat. No. ARG5827 DGCR2 Knockout 786-O Polyclonal Cells DGCR2 Knockout 786-O Polyclonal Cells Cat. No. ARG5681
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Cancer (Tumor) Cell Lines
Species:
Homo sapiens (Human)
Tissue Source:
Urinary bladder
Disease:
Transitional cell carcinoma
Morphology:
Epithelial-like
Growth Mode:
Adherent
Age:
80 years
Sex of Donor:
Female
Derived From Site:
In situ; Urinary bladder
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

No cell engineering information available.

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

MBOAT7 Knockout NCI-H1975 Polyclonal Cells

MBOAT7 Knockout NCI-H1975 Polyclonal Cells

Cat. No. ARG16951
 NFIB Knockout NCI-H1975 Polyclonal Cells

NFIB Knockout NCI-H1975 Polyclonal Cells

Cat. No. ARG16736
 MBP Knockout NCI-H1299 Polyclonal Cells

MBP Knockout NCI-H1299 Polyclonal Cells

Cat. No. ARG17456
 FST Knockout SKOV3 Polyclonal Cells

FST Knockout SKOV3 Polyclonal Cells

Cat. No. ARG12382
 HK1 Knockout HCT116 Polyclonal Cells

HK1 Knockout HCT116 Polyclonal Cells

Cat. No. ARG34781
 IGF2BP3 Knockout T47D Polyclonal Cells

IGF2BP3 Knockout T47D Polyclonal Cells

Cat. No. ARG36803